Novavax Inc (NASDAQ:NVAX)

41.45
Delayed Data
As of 4:00pm ET
 +1.11 / +2.75%
Today’s Change
34.88
Today|||52-Week Range
277.80
-71.03%
Year-to-Date
1 Robinhood Stock to Avoid Right Now
10:30am / MotleyFool.com - Paid Partner Content
3 Companies Growing Revenue Fast
Aug 10 / GuruFocus News - Paid Partner Content
Why Novavax Stock Was Plummeting This Week
7:45am / MotleyFool.com - Paid Partner Content
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
Aug 10 / MotleyFool.com - Paid Partner Content
Novavax's Revenue Could Fall Even More -- and It's Actually Good News
5:52am / MotleyFool.com - Paid Partner Content
Bausch (BHC) Q2 Earnings & Sales Miss, View Cut, Stock Down
Aug 10 / Zacks.com - Paid Partner Content
Is This Battered Growth Stock Still a Buy After Its Latest Stumble?
Aug 11 / MotleyFool.com - Paid Partner Content
Stock Market News for Aug 10, 2022
Aug 10 / Zacks.com - Paid Partner Content
Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
Aug 10 / Zacks.com - Paid Partner Content
Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money by 2026
Aug 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close40.34
Today’s open40.91
Day’s range40.54 - 43.04
Volume139,407
Average volume (3 months)6,903,160
Market cap$4.6B
Data as of 4:00pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)-222.51%
Earnings growth (this year)+203.61%
Earnings growth (next 5 years)-1,485.02%
Revenue growth (last year)+141.02%
P/E ratioNM
Price/Sales9.29
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...+1.17+3.58%
----
ARVNArvinas Inc-0.11-0.20%
----
Data as of 4:00pm ET, 08/12/2022

Financials

Next reporting dateNovember 3, 2022
EPS forecast (this quarter)$4.10
Annual revenue (last year)$1.1B
Annual profit (last year)-$1.7B
Net profit margin-152.12%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts